Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.

Ekbatani A, Asaro LR, Malinow AM.

Int J Obstet Anesth. 2010 Jan;19(1):82-7. doi: 10.1016/j.ijoa.2009.01.012. Epub 2009 Jul 21.

PMID:
19625181
2.

Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.

Wellborn-Kim JJ, Mitchell GA, Terneus WF Jr, Stowe CL, Malias MA, Sparkman GM, Hanson GW.

Am J Health Syst Pharm. 2010 Jul 1;67(13):1075-9. doi: 10.2146/ajhp090394.

PMID:
20554593
3.

Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency.

Tanimura K, Ebina Y, Sonoyama A, Morita H, Miyata S, Yamada H.

J Obstet Gynaecol Res. 2012 Apr;38(4):749-52. doi: 10.1111/j.1447-0756.2011.01758.x. Epub 2012 Mar 2.

PMID:
22380425
4.

How we manage patients with heparin induced thrombocytopenia.

Scully M, Gates C, Neave L.

Br J Haematol. 2016 Jul;174(1):9-15. doi: 10.1111/bjh.14102. Epub 2016 Apr 21. Review.

PMID:
27097741
5.

[Patient with heparin-induced thrombocytopenia type II and implanted left ventricular assist device].

Lutz JT, Exner HJ, Schannewitzky A, Fehske W, Görlinger K.

Anaesthesist. 2008 Jan;57(1):49-52. doi: 10.1007/s00101-007-1297-3. German.

PMID:
18209967
6.

Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.

Gray A, Wallis DE, Hursting MJ, Katz E, Lewis BE.

Clin Appl Thromb Hemost. 2007 Oct;13(4):353-61.

PMID:
17911186
7.

Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.

LaMonte MP, Brown PM, Hursting MJ.

Crit Care Med. 2004 Apr;32(4):976-80.

PMID:
15071388
8.

High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.

Hellwig TR, Peitz GJ, Gulseth MP.

Am J Health Syst Pharm. 2012 Mar 15;69(6):490-5. doi: 10.2146/ajhp110147.

PMID:
22382479
9.

Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.

Levine RL, Hursting MJ, McCollum D.

Chest. 2006 May;129(5):1167-75.

PMID:
16685006
10.

Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.

Yarbrough PM, Varedi A, Walker A, Rondina MT.

Ann Pharmacother. 2012 Nov;46(11):e30. doi: 10.1345/aph.1R226. Epub 2012 Oct 16.

11.

Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.

Hursting MJ, Soffer J.

Drug Saf. 2009;32(3):203-18. doi: 10.2165/00002018-200932030-00003. Review.

PMID:
19338378
12.

Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.

Dager WE, White RH.

Ann Pharmacother. 2003 Sep;37(9):1232-6.

PMID:
12921505
13.

Argatroban use in heparin-induced thrombocytopenia.

Boggio LN, Oza VM.

Expert Opin Pharmacother. 2008 Aug;9(11):1963-7. doi: 10.1517/14656566.9.11.1963 . Review.

PMID:
18627333
14.

Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.

Rice L, Hursting MJ, Baillie GM, McCollum DA.

J Clin Pharmacol. 2007 Aug;47(8):1028-34. Epub 2007 May 24. No abstract available.

PMID:
17525167
15.
17.

Thrombocytopenia following heparin flush.

McNulty I, Katz E, Kim KY.

Prog Cardiovasc Nurs. 2005 Fall;20(4):143-7.

PMID:
16276136
18.

Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.

Ortel TL.

Hematology Am Soc Hematol Educ Program. 2009:225-32. doi: 10.1182/asheducation-2009.1.225. Review.

PMID:
20008202
19.

A case series describing the use of argatroban in patients on extracorporeal circulation.

Cornell T, Wyrick P, Fleming G, Pasko D, Han Y, Custer J, Haft J, Annich G.

ASAIO J. 2007 Jul-Aug;53(4):460-3.

PMID:
17667231
20.

Supplemental Content

Support Center